Cargando…

Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer

BACKGROUND: Combining different cancer treatments represents a promising strategy to improve the therapeutic outcome for lung cancer patients with or without druggable gene alterations. METHODS: We previously developed a polyethylene glycol-based (PEG-based) immunostimulatory nanocarrier (PEG(2k)-Fm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diao, Dingwei, Zhai, Jianxue, Yang, Jianjun, Wu, Hua, Jiang, Jianjun, Dong, Xiaoying, Passaro, Antonio, Aramini, Beatrice, Rao, Shuan, Cai, Kaican
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947404/ https://www.ncbi.nlm.nih.gov/pubmed/33718033 http://dx.doi.org/10.21037/tlcr-21-144

Ejemplares similares

Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
por: Schunke, Jenny, et al.
Publicado: (2023)

Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade
por: Yang, Jianjun, et al.
Publicado: (2020)

Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma
por: Lu, Di, et al.
Publicado: (2020)

Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma”
por: Lu, Di, et al.
Publicado: (2022)

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
por: Chen, Yichao, et al.
Publicado: (2016)

Oesophageal squamous cell carcinoma–associated IL‐33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase
por: Mai, Shijie, et al.
Publicado: (2020)

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
por: Shi, Xiaoshun, et al.
Publicado: (2021)

Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
por: Lu, Di, et al.
Publicado: (2019)

A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
por: Kola Srinivas, Navya Sree, et al.
Publicado: (2016)

High‐throughput membrane‐anchored proteome screening reveals PIEZO1 as a promising antibody‐drug target for human esophageal squamous cell carcinoma
por: Qin, Xun, et al.
Publicado: (2022)

Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers
por: Pizzuto, Malvina, et al.
Publicado: (2017)

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
por: Buss, Colin G., et al.
Publicado: (2020)

The Current Situation of Esophageal Cancer Staging and Perioperative Strategies Determination in Central and Southern China: A Cross Sectional Survey
por: Lu, Di, et al.
Publicado: (2019)

Nanocarrier-Based Drug Delivery for Melanoma Therapeutics
por: Song, Mingming, et al.
Publicado: (2021)

Circular RNA circNELL2 Acts as the Sponge of miR-127-5p to Promote Esophageal Squamous Cell Carcinoma Progression
por: Xiong, Gang, et al.
Publicado: (2020)

Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
por: Zhuang, Jia, et al.
Publicado: (2019)

Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems
por: Weiss, Adam M., et al.
Publicado: (2022)

Inhibition of BPHL inhibits proliferation in lung carcinoma cell lines
por: Ren, Pengfei, et al.
Publicado: (2023)

The first comprehensive database of germline pathogenic variants in East Asian cancer patients
por: Shi, Xiaoshun, et al.
Publicado: (2021)

Magnetic nanocarriers as a therapeutic drug delivery strategy for promoting pain-related motor functions in a rat model of cartilage transplantation
por: Zhang, Xingyu, et al.
Publicado: (2021)

High efficacy of gefitinib in the treatment of EGFR mutation-positive advanced non-small cell lung adenocarcinoma: A case report
por: WANG, ZHONGCHAO, et al.
Publicado: (2014)

Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery
por: Lombardo, Domenico, et al.
Publicado: (2016)

Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
por: Su, Shi, et al.
Publicado: (2020)

Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
por: Majumder, Joydeb, et al.
Publicado: (2020)

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro
por: Long, Rui-Min, et al.
Publicado: (2018)

Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
por: Garland, Kyle M., et al.
Publicado: (2023)

Machine vision-assisted identification of the lung adenocarcinoma category and high-risk tumor area based on CT images
por: Chen, Liuyin, et al.
Publicado: (2022)

A deep learning based CT image analytics protocol to identify lung adenocarcinoma category and high-risk tumor area
por: Chen, Liuyin, et al.
Publicado: (2022)

Identification of the fibroin of Stigmaeopsis nanjingensis by a nanocarrier-based transdermal dsRNA delivery system
por: Li, Xia, et al.
Publicado: (2022)

Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection
por: Agbosu, Esinam E., et al.
Publicado: (2022)

Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics
por: Zhang, Yunhan, et al.
Publicado: (2022)

Lipid Nanoparticle-Mediated Lymphatic Delivery of Immunostimulatory Nucleic Acids
por: Kim, Dongyoon, et al.
Publicado: (2021)

Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
por: Salmaso, Stefano, et al.
Publicado: (2013)

Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents
por: Petroni, Giulia, et al.
Publicado: (2021)

Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents
por: Zhong, Jian, et al.
Publicado: (2022)

Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy
por: Baker, Abu, et al.
Publicado: (2023)

Olmesartan Attenuates Single-Lung Ventilation Induced Lung Injury via Regulating Pulmonary Microbiota
por: Lu, Di, et al.
Publicado: (2022)

Nanocarriers for Nitric Oxide Delivery
por: Saraiva, Juliana, et al.
Publicado: (2011)

Polymeric Nanocarriers for the Delivery of Antimalarials
por: Mhlwatika, Zandile, et al.
Publicado: (2018)

Nanocarriers for Delivery of Oligonucleotides to the CNS
por: Male, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7id98lcpvlm21f6r2ouok5mak0